Compare Nutrien Ltd (NTR) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutrien Ltd vs ResMed Inc. — how do they compare? Nutrien Ltd trades at $66.8 (market cap $31.67B), while ResMed Inc. trades at $197.45 (market cap $28.81B). The key difference: Nutrien Ltd and ResMed Inc. are close in size by market cap, and Nutrien Ltd pays the higher dividend (3.3%). Which is the better fit depends on your goals.
| NTR | RMD | |
|---|---|---|
Market Cap | $31.67B | $28.81B |
Sector | Basic Materials | Health |
52-Week High | $83.94 | $293.73 |
52-Week Low | $53.64 | $182.82 |
Enterprise Value | $44.84B | $27.99B |
Dividend Yield | 3.3% | 1.21% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
